METHODS OF IDENTIFYING COMPOUDS THAT MODULATE IGG MEDIATED MAST CELL ACTIVATION

Details for Australian Patent Application No. 2003258123 (hide)

Owner RIGEL PHARMACEUTICALS, INC.

Inventors ROSSI, Alexander, B.

Pub. Number AU-A-2003258123

PCT Number PCT/US03/24650

PCT Pub. Number WO2004/015389

Priority 60/402,288 09.08.02 US

Filing date 6 August 2003

Wipo publication date 25 February 2004

Event Publications

13 November 2003 Complete Application Filed

  Priority application(s): 60/402,288 09.08.02 US

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2003258123

19 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003258124-LIGHT DELIVERY CATHETER

2003258122-METAL COATED POLYMER ELECTROLYTE MEMBRANE HAVING A REINFORCEMENT STRUCTURE